FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a skin care agent possessing the antifungal properties, containing propolis, ethanol, and a sulphur-containing component, differing the fact that the sulphur-containing component contains elemental nanodispersed sulphur with the components of the agent taken in certain amounts, wt %.
EFFECT: invention provides extending the range of products possessing a wide spectrum of fungicidal action, and promotes the tissue regeneration processes.
3 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR SKIN CARE, POSSESSING ANTIFUNGAL PROPERTIES (VERSIONS) | 2014 |
|
RU2567036C1 |
| ANTIFUNGAL PREPARATION, BASED ON METHYL ETHER OF 2-BENZIMIDAZOLYLCARBAMIC ACID, OR ITS DERIVATIVES | 2013 |
|
RU2546041C2 |
| METHOD FOR SPECIFIC DETECTION OF Trichophyton mentagrophytes IN CLINICAL MATERIAL IN VARIOUS CLINICAL FORMS OF DISEASES | 2014 |
|
RU2563619C1 |
| METHOD OF SPECIFIC DETECTION OF TRICHOPHYTON VERRUCOSUM IN CLINICAL MATERIAL IN CASE OF DIFFERENT CLINICAL FORMS OF DISEASE | 2014 |
|
RU2562540C1 |
| VACCINE FOR PREVENTION AND TREATMENT OF DERMATOPHYTOSES IN ANIMALS | 1991 |
|
RU2020959C1 |
| AGENT POSSESSING ANTIFUNGAL ACTION | 2014 |
|
RU2560517C1 |
| METHOD FOR TREATMENT OF ZOOANTHROPONOSIS TRICHOPHYTOSIS IN CHILDREN | 2005 |
|
RU2289401C1 |
| METHOD OF TREATMENT OF INFILTRATIVE AND SUPPURATIVE TRICHOPHYTOSIS COMPLICATED WITH SECONDARY PYOGENIC INFECTION, AND PREVENTION OF PYOGENIC COMPLICATION OF TRICHOPHYTOSIS COURSE | 2006 |
|
RU2345783C2 |
| 4-(4-METHOXYPHENYL DIAZENYL)-3,5-DIMETHYL-1-(4-NITROPHENYL)-1H-PYRAZOLE WITH ANTIMYCOTIC ACTIVITY AGAINST STRAINS OF PATHOGENIC DERMATOPHYTE FUNGI | 2021 |
|
RU2772381C1 |
| METHOD FOR PREDICTING THE TRANSITION OF AN INFILTRATIVE FORM INTO A SUPPURATION OF A DISEASE IN A PATIENT WITH ZOOANTROPONOZE TRICHOPHYTOSIS | 2019 |
|
RU2714318C1 |
